These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38548249)

  • 41. The Autism Spectrum Disorder-Associated Bacterial Metabolite
    Zheng Y; Prince NZ; Peralta Marzal LN; Ahmed S; Garssen J; Perez Pardo P; Kraneveld AD
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232346
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The cytoplasmic domain of a disintegrin and metalloproteinase 10 (ADAM10) regulates its constitutive activity but is dispensable for stimulated ADAM10-dependent shedding.
    Maretzky T; Evers A; Le Gall S; Alabi RO; Speck N; Reiss K; Blobel CP
    J Biol Chem; 2015 Mar; 290(12):7416-25. PubMed ID: 25605720
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Coxsackievirus and Adenovirus Receptor (CAR) undergoes ectodomain shedding and regulated intramembrane proteolysis (RIP).
    Houri N; Huang KC; Nalbantoglu J
    PLoS One; 2013; 8(8):e73296. PubMed ID: 24015300
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chronic oral application of a periodontal pathogen results in brain inflammation, neurodegeneration and amyloid beta production in wild type mice.
    Ilievski V; Zuchowska PK; Green SJ; Toth PT; Ragozzino ME; Le K; Aljewari HW; O'Brien-Simpson NM; Reynolds EC; Watanabe K
    PLoS One; 2018; 13(10):e0204941. PubMed ID: 30281647
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Elimination of microglia in mouse spinal cord alters the retrograde CNS plasticity observed following peripheral axon injury.
    Hutchinson JM; Isaacson LG
    Brain Res; 2019 Oct; 1721():146328. PubMed ID: 31295468
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The alpha secretase ADAM10: A metalloprotease with multiple functions in the brain.
    Saftig P; Lichtenthaler SF
    Prog Neurobiol; 2015 Dec; 135():1-20. PubMed ID: 26522965
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of a dominant-negative form of ADAM10 in a mouse model of Alzheimer's disease.
    Schroeder A; Fahrenholz F; Schmitt U
    J Alzheimers Dis; 2009; 16(2):309-14. PubMed ID: 19221420
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Shedding of neurexin 3β ectodomain by ADAM10 releases a soluble fragment that affects the development of newborn neurons.
    Borcel E; Palczynska M; Krzisch M; Dimitrov M; Ulrich G; Toni N; Fraering PC
    Sci Rep; 2016 Dec; 6():39310. PubMed ID: 27991559
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Surface expression and limited proteolysis of ADAM10 are increased by a dominant negative inhibitor of dynamin.
    Carey RM; Blusztajn JK; Slack BE
    BMC Cell Biol; 2011 May; 12():20. PubMed ID: 21586144
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tumor necrosis factor alpha induces a metalloprotease-disintegrin, ADAM8 (CD 156): implications for neuron-glia interactions during neurodegeneration.
    Schlomann U; Rathke-Hartlieb S; Yamamoto S; Jockusch H; Bartsch JW
    J Neurosci; 2000 Nov; 20(21):7964-71. PubMed ID: 11050116
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A functional role for ADAM10 in human immunodeficiency virus type-1 replication.
    Friedrich BM; Murray JL; Li G; Sheng J; Hodge TW; Rubin DH; O'Brien WA; Ferguson MR
    Retrovirology; 2011 May; 8():32. PubMed ID: 21569301
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ADAM9 inhibition increases membrane activity of ADAM10 and controls α-secretase processing of amyloid precursor protein.
    Moss ML; Powell G; Miller MA; Edwards L; Qi B; Sang QX; De Strooper B; Tesseur I; Lichtenthaler SF; Taverna M; Zhong JL; Dingwall C; Ferdous T; Schlomann U; Zhou P; Griffith LG; Lauffenburger DA; Petrovich R; Bartsch JW
    J Biol Chem; 2011 Nov; 286(47):40443-51. PubMed ID: 21956108
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Shear stress activates ADAM10 sheddase to regulate Notch1 via the Piezo1 force sensor in endothelial cells.
    Caolo V; Debant M; Endesh N; Futers TS; Lichtenstein L; Bartoli F; Parsonage G; Jones EA; Beech DJ
    Elife; 2020 Jun; 9():. PubMed ID: 32484440
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Bioengineering Strategy to Control ADAM10 Activity in Living Cells.
    Pastore F; Battistoni M; Sollazzo R; Renna P; Paciello F; Li Puma DD; Barone E; Dagliyan O; Ripoli C; Grassi C
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674432
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Over-expression of two different forms of the alpha-secretase ADAM10 affects learning and memory in mice.
    Schmitt U; Hiemke C; Fahrenholz F; Schroeder A
    Behav Brain Res; 2006 Dec; 175(2):278-84. PubMed ID: 17014917
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synapse-associated protein-97 mediates alpha-secretase ADAM10 trafficking and promotes its activity.
    Marcello E; Gardoni F; Mauceri D; Romorini S; Jeromin A; Epis R; Borroni B; Cattabeni F; Sala C; Padovani A; Di Luca M
    J Neurosci; 2007 Feb; 27(7):1682-91. PubMed ID: 17301176
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nuclear translocation and signalling of L1-CAM in human carcinoma cells requires ADAM10 and presenilin/gamma-secretase activity.
    Riedle S; Kiefel H; Gast D; Bondong S; Wolterink S; Gutwein P; Altevogt P
    Biochem J; 2009 May; 420(3):391-402. PubMed ID: 19260824
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 1,25-Dihydroxyvitamin D3 Attenuates the Effects of Lipopolysaccharide by Causing ADAM10-Dependent Ectodomain Shedding of Toll-Like Receptor 4.
    Yang WS; Kim JJ; Han NJ; Lee EK; Park SK
    Cell Physiol Biochem; 2017; 41(5):2104-2116. PubMed ID: 28427048
    [TBL] [Abstract][Full Text] [Related]  

  • 59. GDE2-RECK controls ADAM10 α-secretase-mediated cleavage of amyloid precursor protein.
    Nakamura M; Li Y; Choi BR; Matas-Rico E; Troncoso J; Takahashi C; Sockanathan S
    Sci Transl Med; 2021 Mar; 13(585):. PubMed ID: 33731436
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MicroRNA-144 is regulated by activator protein-1 (AP-1) and decreases expression of Alzheimer disease-related a disintegrin and metalloprotease 10 (ADAM10).
    Cheng C; Li W; Zhang Z; Yoshimura S; Hao Q; Zhang C; Wang Z
    J Biol Chem; 2013 May; 288(19):13748-61. PubMed ID: 23546882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.